KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) Research & Development (2016 - 2025)

Historic Research & Development for Imax (IMAX) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • Imax's Research & Development rose 66792.45% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 1737.83%. This contributed to the annual value of $5.1 million for FY2024, which is 4952.52% down from last year.
  • Per Imax's latest filing, its Research & Development stood at $1.5 million for Q3 2025, which was up 66792.45% from $1.5 million recorded in Q2 2025.
  • Imax's Research & Development's 5-year high stood at $2.8 million during Q3 2023, with a 5-year trough of -$265000.0 in Q3 2024.
  • Over the past 5 years, Imax's median Research & Development value was $1.5 million (recorded in 2025), while the average stood at $1.7 million.
  • Per our database at Business Quant, Imax's Research & Development crashed by 10956.33% in 2024 and then surged by 66792.45% in 2025.
  • Over the past 5 years, Imax's Research & Development (Quarter) stood at $1.2 million in 2021, then surged by 30.85% to $1.6 million in 2022, then soared by 66.69% to $2.7 million in 2023, then plummeted by 57.75% to $1.2 million in 2024, then skyrocketed by 30.87% to $1.5 million in 2025.
  • Its Research & Development was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.3 million in Q1 2025.